Cause of death, by non-communicable diseases, female in Central Europe and the Baltics
Central Europe and the Baltics: Cause of death, by non-communicable diseases, female was 76.6% in 2021. ▼ Falling
Cause of death, by non-communicable diseases, female in Central Europe and the Baltics, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total female deaths.
Analysis
In 2021, cause of death, by non-communicable diseases, female in Central Europe and the Baltics stood at 76.6%. That is the lowest value across all 6 years on record.
The figure is down 10.7% on the previous year and down 18.6% over ten years.
Over the whole period, cause of death, by non-communicable diseases, female in Central Europe and the Baltics peaked at 94.1% in 2010 and was at its lowest, 76.6%, in 2021.
That places Central Europe and the Baltics 11th out of 47 groups with data for 2021, putting it in the top quarter.
Cause of death, by non-communicable diseases, female in Central Europe and the Baltics, year by year
| Year | % of total female deaths | Change |
|---|---|---|
| 2000 | 92.8% | — |
| 2010 | 94.1% | +1.5% |
| 2015 | 93.7% | -0.5% |
| 2019 | 92.9% | -0.8% |
| 2020 | 85.8% | -7.7% |
| 2021 | 76.6% | -10.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 92.8% | 92.8% | 92.8% | 1 |
| 2010s | 93.6% | 92.9% | 94.1% | 3 |
| 2020s | 81.2% | 76.6% | 85.8% | 2 |
Countries ranked near Central Europe and the Baltics
More health data for Central Europe and the Baltics
- Population ages 30-34, male, annual growth rate -4.09 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.037 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate -1.57 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0352 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, female, annual growth rate -1.55 % change on previous year (2025)
- Population ages 30-34, male, per capita 0.0319 units per person (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 25-29, male, annual growth rate -3.51 % change on previous year (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, female in Central Europe and the Baltics?
- Cause of death, by non-communicable diseases, female in Central Europe and the Baltics was 76.6% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, female recorded in Central Europe and the Baltics?
- The highest recorded value was 94.1% in 2010.
- What is the lowest cause of death, by non-communicable diseases, female recorded in Central Europe and the Baltics?
- The lowest recorded value was 76.6% in 2021.
- How does Central Europe and the Baltics rank for cause of death, by non-communicable diseases, female?
- Central Europe and the Baltics ranks 11th out of 47 groups with data for 2021.
- Is cause of death, by non-communicable diseases, female rising or falling in Central Europe and the Baltics?
- Over the last ten years it is down 18.6%. The long-run trend across the full record is falling.
- Where does this Central Europe and the Baltics data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.